Ziwen Qiu

Title: Innovations of Ziwen Qiu in Avian Influenza Vaccine Development.

Introduction

Ziwen Qiu is a notable inventor based in Guangdong, China. She has made significant contributions to the field of avian influenza research, particularly in the development of vaccines. Her innovative work has the potential to impact public health and animal health significantly.

Latest Patents

Ziwen Qiu holds a patent for a "Whole avian-origin reverse genetic system and its use in producing H7N9 subtype avian influenza vaccine." This patent discloses a comprehensive avian-origin reverse genetic manipulation system designed to produce a recombinant H7N9 avian influenza vaccine. The system is based on the H5N2 subtype avian influenza D7 virus strain and consists of eight recombinant plasmids containing essential gene fragments. The resulting vaccine incorporates a modified HA gene and an NA gene derived from a highly pathogenic H7N9 strain, along with other genes from the H5N2 strain.

Career Highlights

Ziwen Qiu is affiliated with South China Agricultural University, where she continues her research and development efforts. Her work is crucial in addressing the challenges posed by avian influenza viruses. She has demonstrated a commitment to advancing scientific knowledge and improving vaccine technology.

Collaborations

Ziwen collaborates with esteemed colleagues, including Wenbao Qi and Ming Liao. These partnerships enhance her research capabilities and contribute to the success of her innovative projects.

Conclusion

Ziwen Qiu's contributions to avian influenza vaccine development exemplify the importance of innovation in public health. Her work not only addresses immediate health concerns but also paves the way for future advancements in vaccine technology.